Sulfo-Cyanine3.5 NHS ester
| Cat. # | Quantity | Price | Lead time | Buy this product |
|---|---|---|---|---|
| 12320 | 1 mg | $110.00 | in stock | |
| 22320 | 5 mg | $290.00 | in stock | |
| 42320 | 25 mg |
$690.00
|
in stock | |
| 52320 | 50 mg |
$1270.00
|
in stock | |
| 62320 | 100 mg |
$1990.00
|
in stock |
Cyanine3.5 is a fluorescent dye with absorption and emission intermediate between Cyanine3 and Cyanine5. Sulfonated version contains four sulfo groups which ensure high solubility and hydrophilicity of the fluorophore and labeled conjugates.
The NHS ester reactive group allows to label primary and secondary amine groups.
Absorption and emission spectra of sulfo-Cyanine3.5
Customers also purchased with this product
Sulfo-Cyanine5.5 maleimide
Sulfo-Cyanine5.5 is a water-soluble far red emitting dye. This is a thiol reactive maleimide derivative of sulfo-Cyanine5.5. It is recommended for the labeling of sensitive proteins.AF488 NHS ester
AF488 (Alexa Fluor 488) NHS ester, a bright, photostable and hydrophilic fluorescent dye for green channel.EDC, coupling grade
Water soluble carbodiimide for the coupling of carboxylic acids with amines.General properties
| Appearance: | deep purple powder |
| Molecular weight: | 1088.33 |
| CAS number: | 2231670-91-8 (without cation) |
| Molecular formula: | C42H40N3K3O16S4 |
| Solubility: | good in water, DMF, DMSO |
| Quality control: | NMR 1H, HPLC-MS (95%) |
| Storage conditions: | Storage: 12 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
| MSDS: | Download |
| Product specifications |
Spectral properties
| Excitation/absorption maximum, nm: | 576 |
| ε, L⋅mol−1⋅cm−1: | 139000 |
| Emission maximum, nm: | 603 |
| Fluorescence quantum yield: | 0.11 |
| CF260: | 0.16 |
| CF280: | 0.17 |
Product citations
- Shramova, E.; Proshkina, G.; Shipunova, V.; Ryabova, A.; Kamyshinsky, R.; Konevega, A.; Schulga, A.; Konovalova, E.; Telegin, G.; Deyev, S. Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape. Cancers, 2020, 12(10), 3014. doi: 10.3390/cancers12103014
The count of items is incorrect.
Your cart is empty
$ 
